Page 518 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

28. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. atrial fibrillation of the European Society of Cardiology (ESC).
Treating electrical storm: sympathetic blockade versus Eur Heart J. 2010;31(19):2369-2429.
advanced cardiac life support-guided therapy. Circulation. 42. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of
2000;102(7):742-747. atrial fibrillation by ectopic beats originating in the pulmonary
29. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser veins. N Engl J Med. 1998;339(10):659-666.
SH. Electrical storm in patients with transvenous implantable 43. Chauhan VS, Krahn AD, Klein GJ, Skanes AC, Yee R.
cardioverter-defibrillators: incidence, management and prog- Supraventricular tachycardia. Med Clin North Am.
nostic implications. J Am Coll Cardiol. 1998;32(7):1909-1915. 2001;85(2):193-223, ix.
30. Kowey PR, Levine JH, Herre JM, et al. Randomized, double- 44. Gillis AM, Verma A, Talajic M, Nattel S, Dxorian P. Canadian
blind comparison of intravenous amiodarone and bretylium cardiovascular society atrial fibrillation guidelines 2010: rate
in the treatment of patients with recurrent, hemodynami- and rhythm management. Can J Cardiol. 2011;27(1):47-59.
cally destabilizing ventricular tachycardia or fibrillation. The
Intravenous Amiodarone Multicenter Investigators Group. 45. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus
Circulation. 1995;92(11):3255-3263. strict rate control in patients with atrial fibrillation. N Engl J
31. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Med. 2010;362(15):1363-1373.
Hafley G. Arandomized study of the prevention of sudden 46. Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M.
death in patients with coronary artery disease. Multicenter Canadian cardiovascular society atrial fibrillation guidelines
Unsustained Tachycardia Trial Investigators. N Engl J Med. 2010: prevention of stroke and systemic thromboembolism in
1999;341(25):1882-1890. atrial fibrillation and flutter. Can J Cardiol. 2011;27(1):74-90.
32. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implant- 47. Kochiadakis GE, Igoumenidis NE, Simantirakis EN, et al.
able cardioverter-defibrillator for congestive heart failure. N Intravenous propafenone versus intravenous amiodarone in
Engl J Med. 2005;352(3):225-237. the management of atrial fibrillation of recent onset: a placebo-
33. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation controlled study. Pacing Clin Electrophysiol. 1998;21(11 Pt 2):
of a defibrillator in patients with myocardial infarction and 2475-2479.
reduced ejection fraction. N Engl J Med. 2002;346(12):877-883. 48. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate
34. The Antiarrhythmics Versus Implantable Defibrillators control and rhythm control in patients with atrial fibrillation.
(AVID) Investigators. A comparison of antiarrhythmic-drug N Engl J Med. 2002;347(23):1825-1833.
therapy with implantable defibrillators in patients resusci- 49. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of
tated from near-fatal ventricular arrhythmias. N Engl J Med. rate control and rhythm control in patients with recurrent per-
1997;337(22):1576-1583. sistent atrial fibrillation. N Engl J Med. 2002;347(23):1834-1840.
35. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable 50. Newman D, Gillis A, Gilbert M, Dorian P. Long term drug
defibrillator study (CIDS): a randomized trial of the implant- therapy for the prevention of recurrence in atrial fibrillation.
able cardioverter defibrillator against amiodarone. Circulation. Can J Cardiol. 1996;12(suppl A):21A-26A.
2000;101(11):1297-1302. 51. Patel C, Yan GX, Kowey PR. Dronedarone. Circulation.
36. Sy RW, Gollob MH, Klein GJ, et al. Arrhythmia characterization 2009;120(7):636-644.
and long-term outcomes in catecholaminergic polymorphic 52. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators.
ventricular tachycardia. Heart Rhythm. 2011;8(6):864-871. Preliminary report: effect of encainide and flecainide on mor-
37. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade tality in a randomized trial of arrhythmia suppression after
de pointes with magnesium sulfate. Circulation. 1988;77(2): myocardial infarction. N Engl J Med. 1989;321(6):406-412.
392-397. 53. Waldo AL, Camm AJ, deRuyter H, et al. Effect of D-sotalol on
38. Viskin S. Cardiac pacing in the long QT syndrome: review of mortality in patients with left ventricular dysfunction after recent
available data and practical recommendations. J Cardiovasc and remote myocardial infarction. The SWORD Investigators.
Electrophysiol. 2000;11(5):593-600. Survival With Oral D-Sotalol. Lancet. 1996;348(9019):7-12.
39. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of 54. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical
the implantable cardioverter defibrillator secondary preven- outcomes after ablation and pacing therapy for atrial fibrillation:
tion trials. AVID, CASH and CIDS studies. Antiarrhythmics vs a meta-analysis. Circulation. 2000;101(10):1138-1144.
Implantable Defibrillator study. Cardiac Arrest Study Hamburg.
Canadian Implantable Defibrillator Study. Eur Heart J. 55. Jais P, Weerasooriya R, Shah DC, et al. Ablation therapy for
2000;21(24):2071-2078. atrial fibrillation (AF): past, present and future. Cardiovasc Res.
40. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 2002;54(2):337-346.
guidelines for the management of patients with atrial fibrilla- 56. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic
tion—executive summary: a report of the American College of therapy to prevent stroke in patients with atrial fibrillation: a
Cardiology/American Heart Association Task Force on Practice meta-analysis. Ann Intern Med. 1999;131(7):492-501.
Guidelines and the European Society of Cardiology Committee 57. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran ver-
for Practice Guidelines (Writing Committee to Revise the sus warfarin in patients with atrial fibrillation. N Engl J Med.
2001 Guidelines for the Management of Patients With Atrial 2009;361(12):1139-1151.
Fibrillation). J Am Coll Cardiol. 2006;48(4):854-906. 58. Yee R, Connolly S, Noorani H. Clinical review of radiofre-
41. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the manage- quency catheter ablation for cardiac arrhythmias. Can J Cardiol.
ment of atrial fibrillation: the task force for the management of 2003;19(11):1273-1284.

Section03-O-ref.indd 2 1/20/2015 7:10:23 AM